Cargando…
Differential responses to doxorubicin-induced phosphorylation and activation of Akt in human breast cancer cells
INTRODUCTION: We have shown previously that overexpression of constitutively active Akt or activation of Akt caused by constitutively active Ras or human epidermal growth factor receptor-2 (HER2) confers on breast cancer cells resistance to chemotherapy or radiotherapy. As an expanded study we here...
Autores principales: | Li, Xinqun, Lu, Yang, Liang, Ke, Liu, Bolin, Fan, Zhen |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1242125/ https://www.ncbi.nlm.nih.gov/pubmed/16168102 http://dx.doi.org/10.1186/bcr1259 |
Ejemplares similares
-
Responses of cancer cells with wild-type or tyrosine kinase domain-mutated epidermal growth factor receptor (EGFR) to EGFR-targeted therapy are linked to downregulation of hypoxia-inducible factor-1α
por: Lu, Yang, et al.
Publicado: (2007) -
Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer
por: Lin, H-J, et al.
Publicado: (2005) -
Decrotonylation of AKT1 promotes AKT1 phosphorylation and activation during myogenic differentiation
por: Qian, Zhengyu, et al.
Publicado: (2022) -
Tau Phosphorylation and μ-Calpain Activation Mediate the Dexamethasone-Induced Inhibition on the Insulin-Stimulated Akt Phosphorylation
por: Liu, Yudong, et al.
Publicado: (2012) -
PFKM inhibits doxorubicin-induced cardiotoxicity by enhancing oxidative phosphorylation and glycolysis
por: Zhou, Min, et al.
Publicado: (2022)